CRISPR Therapeutics Stock Options

CRSP
 Stock
  

USD 81.40  2.49  3.16%   

CRISPR Therapeutics' option chain provides insight into all available option contracts written on CRISPR Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of CRISPR Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given CRISPR option contract. View S&P 500 options
  
Purchasing CRISPR Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" CRISPR calls. Remember, the seller must deliver CRISPR Therapeutics AG stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on CRISPR Therapeutics

Analyzing CRISPR Therapeutics' in-the-money options over time can help investors to take a profitable long position in CRISPR Therapeutics regardless of its overall volatility. This is especially true when CRISPR Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money CRISPR Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with CRISPR Therapeutics' stock while costing only a fraction of its price.
CRISPR Therapeutics' latest option contracts expiring on 2022-08-12 are carrying combined implied volatility of 69.45 with a put-to-call open interest ratio of 0.81 over 130 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2022-08-12. The current put volume is at 401, with calls trading at the volume of 1267. This yields a 0.32 put-to-call volume ratio. The CRISPR Therapeutics option chain provides detailed quote and price information for the current CRISPR Therapeutics AG option contracts. It shows all of CRISPR Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-08-12 Option Contracts

CRISPR Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in CRISPR Therapeutics' lending market. For example, when CRISPR Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on CRISPR Therapeutics, he or she must hedge the risk by shorting CRISPR Therapeutics stock over its option's life.
The chart above shows CRISPR Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. CRISPR Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for CRISPR Therapeutics' option, there is no secondary market available for investors to trade.

CRISPR Therapeutics Maximum Pain Price across 2022-08-12 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as CRISPR Therapeutics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
CRISPR Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of CRISPR Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell CRISPR stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If CRISPR Therapeutics' stock price goes up or down, the stock options follow.
Continue to Trending Equities.
Please note that buying 'in-the-money' options on CRISPR Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if CRISPR Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money CRISPR Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if CRISPR Stock moves the wrong way.
As of 8th of August 2022, Net Income Common Stock is likely to grow to about 407.5 M

CRISPR Therapeutics In The Money Call Balance

When CRISPR Therapeutics' strike price is surpassing the current stock price, the option contract against CRISPR Therapeutics AG stock is said to be in the money. When it comes to buying CRISPR Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on CRISPR Therapeutics AG are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

CRISPR Current Options Market Mood

CRISPR Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps CRISPR Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of CRISPR Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. CRISPR Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current CRISPR Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current CRISPR contract

Base on the Rule 16, the options market is currently suggesting that CRISPR Therapeutics AG will have an average daily up or down price movement of about 4.34% per day over the life of the 2022-08-12 option contract. With CRISPR Therapeutics trading at $81.4, that is roughly $3.53. If you think that the market is fully incorporating CRISPR Therapeutics' daily price movement you should consider buying CRISPR Therapeutics AG options at the current volatility level of 69.45%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

CRISPR Therapeutics Option Chain

When CRISPR Therapeutics' strike price is surpassing the current stock price, the option contract against CRISPR Therapeutics AG stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2022-08-122022-08-192022-08-262022-09-022022-09-092022-09-162022-09-232022-10-212023-01-202024-01-19
CRISPR Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on CRISPR. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for CRISPR. It also shows strike prices and maturity days for a CRISPR Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2022-08-12 CALL at $35.00.94680.00202022-08-1244.0 - 48.00.0In
Call
2022-08-12 CALL at $40.00.940.002602022-08-1239.4 - 42.90.0In
Call
2022-08-12 CALL at $45.00.93270.003402022-08-1234.2 - 37.80.0In
Call
2022-08-12 CALL at $49.00.93030.004102022-08-1230.5 - 33.60.0In
Call
2022-08-12 CALL at $50.00.92470.004402022-08-1229.1 - 32.70.0In
Call
2022-08-12 CALL at $51.00.91590.004802022-08-1228.3 - 31.90.0In
Call
2022-08-12 CALL at $52.00.90440.005102022-08-1227.0 - 31.20.0In
Call
2022-08-12 CALL at $53.00.89860.005402022-08-1226.2 - 30.30.0In
Call
2022-08-12 CALL at $54.00.9010.005702022-08-1225.3 - 29.10.0In
Call
2022-08-12 CALL at $55.00.89470.006102022-08-1224.2 - 28.20.0In
Call
2022-08-12 CALL at $56.00.89430.006402022-08-1223.2 - 27.10.0In
Call
2022-08-12 CALL at $57.00.95880.004922022-08-1222.5 - 27.016.99In
Call
2022-08-12 CALL at $58.00.99380.001502022-08-1221.7 - 25.20.0In
Call
2022-08-12 CALL at $59.00.86740.007712022-08-1220.0 - 24.620.08In
Call
2022-08-12 CALL at $60.00.89450.0082102022-08-1219.6 - 22.714.85In
Call
2022-08-12 CALL at $61.00.96240.005902022-08-1219.1 - 22.20.0In
Call
2022-08-12 CALL at $62.00.87740.009402022-08-1217.4 - 20.90.0In
Call
2022-08-12 CALL at $63.00.88170.010102022-08-1216.4 - 19.70.0In
Call
2022-08-12 CALL at $64.00.89310.010702022-08-1215.8 - 18.40.0In
Call
2022-08-12 CALL at $65.00.92650.010432022-08-1215.1 - 18.714.2In
Call
2022-08-12 CALL at $66.00.96020.008592022-08-1214.7 - 16.511.7In
Call
2022-08-12 CALL at $67.00.86540.013852022-08-1212.9 - 15.610.92In
Call
2022-08-12 CALL at $68.00.9910.003892022-08-1212.0 - 14.99.45In
Call
2022-08-12 CALL at $69.00.96290.010452022-08-1211.1 - 14.09.4In
Call
2022-08-12 CALL at $70.00.90420.017262022-08-1210.8 - 13.08.94In
Call
2022-08-12 CALL at $71.00.78590.0181102022-08-129.1 - 12.69.49In
Call
2022-08-12 CALL at $72.00.88450.022282022-08-128.7 - 11.25.71In
Call
2022-08-12 CALL at $73.00.86360.025632022-08-128.1 - 10.06.38In
Call
2022-08-12 CALL at $74.00.8360.029442022-08-127.1 - 9.34.62In
Call
2022-08-12 CALL at $75.00.86150.0345702022-08-126.4 - 8.36.9In
Call
2022-08-12 CALL at $76.00.81180.0405112022-08-125.6 - 6.75.23In
Call
2022-08-12 CALL at $77.00.73970.0424152022-08-124.8 - 6.15.7In
Call
2022-08-12 CALL at $78.00.69420.0461332022-08-124.6 - 5.35.0In
Call
2022-08-12 CALL at $79.00.64730.0499382022-08-123.4 - 4.64.3In
Call
2022-08-12 CALL at $80.00.59980.0561862022-08-123.5 - 4.63.5In
Call
2022-08-12 CALL at $81.00.54240.059392022-08-122.05 - 3.62.9In
Call
2022-08-12 CALL at $82.00.48810.0537332022-08-121.55 - 3.12.7Out
Call
2022-08-12 CALL at $83.00.42520.0582292022-08-121.15 - 2.552.0Out
Call
2022-08-12 CALL at $84.00.36060.0587302022-08-121.45 - 2.21.5Out
Call
2022-08-12 CALL at $85.00.33490.0493852022-08-121.45 - 1.81.56Out
Call
2022-08-12 CALL at $86.00.29950.0449442022-08-120.9 - 2.151.4Out
Call
2022-08-12 CALL at $87.00.24320.0431182022-08-120.1 - 1.21.0Out
Call
2022-08-12 CALL at $88.00.19140.03951552022-08-120.05 - 1.00.7Out
Call
2022-08-12 CALL at $89.00.17260.034952022-08-120.0 - 1.70.65Out
Call
2022-08-12 CALL at $90.00.13730.0307612022-08-120.45 - 0.650.48Out
Call
2022-08-12 CALL at $91.00.15760.0282102022-08-120.35 - 1.00.3Out
Call
2022-08-12 CALL at $92.00.10160.0236122022-08-120.25 - 0.50.35Out
Call
2022-08-12 CALL at $93.00.10510.022192022-08-120.2 - 1.00.4Out
Call
2022-08-12 CALL at $94.00.0890.0193212022-08-120.15 - 0.40.33Out
Call
2022-08-12 CALL at $95.00.07840.0171212022-08-120.0 - 0.30.29Out
Call
2022-08-12 CALL at $96.00.05850.014112022-08-120.05 - 0.350.35Out
Call
2022-08-12 CALL at $97.00.0610.013602022-08-120.05 - 0.40.0Out
Call
2022-08-12 CALL at $98.00.04940.011502022-08-120.05 - 0.30.0Out
Call
2022-08-12 CALL at $99.00.1030.015102022-08-120.05 - 1.050.0Out
Call
2022-08-12 CALL at $100.00.05070.0106182022-08-120.05 - 0.250.2Out
Call
2022-08-12 CALL at $101.00.09750.013502022-08-120.0 - 1.050.0Out
Call
2022-08-12 CALL at $102.00.09220.012702022-08-120.0 - 1.00.0Out
Call
2022-08-12 CALL at $103.00.090.012102022-08-120.0 - 1.00.0Out
Call
2022-08-12 CALL at $104.00.08790.011502022-08-120.0 - 1.00.0Out
Call
2022-08-12 CALL at $105.00.05880.009322022-08-120.0 - 0.550.1Out
Call
2022-08-12 CALL at $106.00.08150.010402022-08-120.05 - 0.950.0Out
Call
2022-08-12 CALL at $107.00.07980.0102022-08-120.05 - 0.950.0Out
Call
2022-08-12 CALL at $108.00.07290.009302022-08-120.05 - 0.850.0Out
Call
2022-08-12 CALL at $109.00.07680.009202022-08-120.05 - 0.950.0Out
Call
2022-08-12 CALL at $110.00.03190.0057202022-08-120.05 - 0.20.15Out
 Put
2022-08-12 PUT at $58.0-0.06990.006602022-08-120.0 - 1.350.0Out
 Put
2022-08-12 PUT at $59.0-0.07250.00702022-08-120.0 - 1.350.08Out
 Put
2022-08-12 PUT at $60.0-0.05110.0065182022-08-120.0 - 0.70.3Out
 Put
2022-08-12 PUT at $61.0-0.01270.00332022-08-120.0 - 1.150.05Out
 Put
2022-08-12 PUT at $62.0-0.03650.006202022-08-120.0 - 1.50.2Out
 Put
2022-08-12 PUT at $63.0-0.04450.007322022-08-120.05 - 0.450.65Out
 Put
2022-08-12 PUT at $64.0-0.03660.00732022-08-120.0 - 0.30.85Out
 Put
2022-08-12 PUT at $65.0-0.0490.0088122022-08-120.0 - 0.250.25Out
 Put
2022-08-12 PUT at $66.0-0.05810.0102282022-08-120.05 - 0.30.3Out
 Put
2022-08-12 PUT at $67.0-0.05450.010772022-08-120.05 - 0.250.25Out
 Put
2022-08-12 PUT at $68.0-0.04090.0101132022-08-120.05 - 0.250.45Out
 Put
2022-08-12 PUT at $69.0-0.03730.0105572022-08-120.1 - 0.250.12Out
 Put
2022-08-12 PUT at $70.0-0.06520.0151722022-08-120.15 - 0.30.25Out
 Put
2022-08-12 PUT at $71.0-0.08590.0185132022-08-120.05 - 1.20.35Out
 Put
2022-08-12 PUT at $72.0-0.09970.0216172022-08-120.25 - 0.50.4Out
 Put
2022-08-12 PUT at $73.0-0.12830.025572022-08-120.4 - 0.60.55Out
 Put
2022-08-12 PUT at $74.0-0.15690.0295412022-08-120.5 - 0.90.91Out
 Put
2022-08-12 PUT at $75.0-0.18640.0337712022-08-120.0 - 1.550.85Out
 Put
2022-08-12 PUT at $76.0-0.21770.038432022-08-120.85 - 2.151.0Out
 Put
2022-08-12 PUT at $77.0-0.27740.039692022-08-120.5 - 2.31.53Out
 Put
2022-08-12 PUT at $78.0-0.31760.0431132022-08-121.1 - 1.951.8Out
 Put
2022-08-12 PUT at $79.0-0.34830.051982022-08-121.25 - 2.252.35Out
 Put
2022-08-12 PUT at $80.0-0.41160.0464202022-08-121.3 - 3.72.65Out
 Put
2022-08-12 PUT at $81.0-0.45890.0513112022-08-122.15 - 3.22.87Out
 Put
2022-08-12 PUT at $82.0-0.52770.0724122022-08-122.25 - 3.72.5In
 Put
2022-08-12 PUT at $83.0-0.5740.057612022-08-122.9 - 4.36.5In
 Put
2022-08-12 PUT at $84.0-0.63130.056102022-08-123.5 - 4.90.0In
 Put
2022-08-12 PUT at $85.0-0.69150.0544402022-08-124.0 - 5.610.95In
 Put
2022-08-12 PUT at $86.0-0.69840.044502022-08-125.6 - 6.40.0In
 Put
2022-08-12 PUT at $87.0-0.74880.042402022-08-125.9 - 7.40.0In
 Put
2022-08-12 PUT at $88.0-0.7860.038702022-08-126.7 - 8.20.0In
 Put
2022-08-12 PUT at $89.0-0.8170.034902022-08-127.2 - 9.40.0In
 Put
2022-08-12 PUT at $90.0-0.83370.031202022-08-127.4 - 11.10.0In
 Put
2022-08-12 PUT at $91.0-0.81830.028202022-08-128.8 - 12.10.0In
 Put
2022-08-12 PUT at $92.0-0.93610.019802022-08-129.1 - 12.40.0In
 Put
2022-08-12 PUT at $93.0-0.87570.02302022-08-1210.5 - 13.70.0In
 Put
2022-08-12 PUT at $94.0-0.88090.021102022-08-1211.5 - 14.70.0In
 Put
2022-08-12 PUT at $95.0-0.88550.019502022-08-1212.7 - 15.50.0In
 Put
2022-08-12 PUT at $96.0-0.95950.011702022-08-1212.9 - 16.50.0In
 Put
2022-08-12 PUT at $97.0-0.89990.016602022-08-1214.2 - 17.90.0In
 Put
2022-08-12 PUT at $98.0-0.89670.015902022-08-1215.3 - 18.90.0In
 Put
2022-08-12 PUT at $99.0-0.91950.013802022-08-1216.3 - 19.60.0In
 Put
2022-08-12 PUT at $100.0-0.92180.01302022-08-1217.0 - 20.90.0In
 Put
2022-08-12 PUT at $101.0-0.9240.012302022-08-1218.0 - 21.90.0In
 Put
2022-08-12 PUT at $102.0-0.91340.012402022-08-1219.5 - 22.60.0In
 Put
2022-08-12 PUT at $103.0-0.92790.011102022-08-1220.0 - 23.90.0In
 Put
2022-08-12 PUT at $104.0-0.92960.010502022-08-1221.1 - 24.80.0In
 Put
2022-08-12 PUT at $105.0-0.93120.010102022-08-1222.0 - 25.90.0In
 Put
2022-08-12 PUT at $106.0-0.93270.009602022-08-1223.0 - 26.90.0In
 Put
2022-08-12 PUT at $107.0-0.93410.009202022-08-1224.0 - 27.90.0In
 Put
2022-08-12 PUT at $108.0-0.93540.008802022-08-1225.0 - 28.90.0In
 Put
2022-08-12 PUT at $109.0-0.9310.008802022-08-1226.1 - 29.90.0In
 Put
2022-08-12 PUT at $110.0-0.93780.008202022-08-1227.0 - 30.90.0In

CRISPR Therapeutics Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends Income Statement Impact.
   Net Income Common Stock   
Share
       Timeline  

CRISPR Therapeutics Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of CRISPR Therapeutics, understanding its historical liability is critical in projecting CRISPR Therapeutics' future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how CRISPR Therapeutics uses its financing power over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in CRISPR Therapeutics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Pair Trading with CRISPR Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CRISPR Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with CRISPR Therapeutics

0.75BLUBellus Health Earnings Call  TomorrowPairCorr

Moving against CRISPR Therapeutics

0.88BBIBrickell Biotech Earnings Call  This WeekPairCorr
0.86INMInmed Pharmaceuticals Fiscal Year End 23rd of September 2022 PairCorr
0.55BCLIBrainstorm Cell Earnings Call  This WeekPairCorr
The ability to find closely correlated positions to CRISPR Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CRISPR Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CRISPR Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CRISPR Therapeutics AG to buy it.
The correlation of CRISPR Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CRISPR Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CRISPR Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CRISPR Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the CRISPR Therapeutics information on this page should be used as a complementary analysis to other CRISPR Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for CRISPR Stock analysis

When running CRISPR Therapeutics price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is CRISPR Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CRISPR Therapeutics. If investors know CRISPR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CRISPR Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
6.3 B
Quarterly Revenue Growth YOY
0.74
Return On Assets
0.0855
Return On Equity
0.15
The market value of CRISPR Therapeutics is measured differently than its book value, which is the value of CRISPR that is recorded on the company's balance sheet. Investors also form their own opinion of CRISPR Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CRISPR Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CRISPR Therapeutics' market value can be influenced by many factors that don't directly affect CRISPR Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CRISPR Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine CRISPR Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CRISPR Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.